NEW YORK (GenomeWeb) – A new assessment of the clinical utility of exome sequencing suggests that the test can significantly impact clinical management. A study of 78 patients who underwent exome testing at the pediatric neurogenetics clinic of the Kennedy Krieger Institute in Baltimore showed that all patients and their families with a positive result – about 40 percent – saw changes in the management of their disease.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.